US$ 26.35
bpc 157 recommended dosage for regeneration BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or TB-500 Peptide: Benefits, Dosage &
Description
Results on its efficacy are conflicting, with some studies showing positive effect and others showing no effect

The BPC-157 cancer risk concern centers on its VEGFR2 upregulation

When given intraperitoneally (i.e., 10 g/kg b.w.), NaBPC157 was shown to prevent the development of alloxan as well as streptozotocin induced diabetes in rats

Supplementing with highquality peptides helps support the bodys ability to restore balance and function optimally
